Australia markets open in 3 hours 5 minutes

Precipio, Inc. (PRPO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.2000+0.0400 (+1.85%)
At close: 4:00PM EDT

Precipio, Inc.

4 Science Park
New Haven, CT 06511
United States
203 787 7888
http://www.precipiodx.com

Sector(s)Healthcare
IndustryDiagnostics & Research
Full-time employees50

Key executives

NameTitlePayExercisedYear born
Mr. Ilan DanieliFounder, Pres, CEO & Director263.56kN/A1972
Mr. Carl R. IbergerCFO & Sec.210.67kN/A1953
Mr. Ahmed Zaki SabetChief Operating Officer173.76kN/A1987
Mr. Stephen R. MillerChief Commercial Officer252.21kN/A1966
Ms. Miri Chiko-RadomskiGen. CounselN/AN/AN/A
Mr. Douglas SitesVP of SalesN/AN/AN/A
Mr. Ayman Mohamed M.D.Sr. VP of R&D and Laboratory OperationsN/AN/A1986
Mr. Ori KarevChief Strategy OfficerN/AN/AN/A
Amounts are as of 31 December 2019, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Precipio, Inc., a cancer diagnostics company, provides diagnostic products and services in the United States oncology market. Its product consists of clinical diagnostic services. The company's clinical diagnostic services focus on the diagnosis of different hematopoietic or blood-related cancers to oncologists. Its cytogenetics media IV-Cell enables laboratories to arrive at more accurate results; and HemeScreen panel enables hospitals and laboratories to run an important genetic mutation test. It serves oncologists, hospitals, reference laboratories, and pharma and biotech companies. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment, such as the Yale School of Medicine and Harvard's Dana-Farber Cancer Institute. The company is based in New Haven, Connecticut.

Corporate governance

Precipio, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.